Screener/Healthcare/Biotechnology

RXRX

Recursion Pharmaceuticals, Inc.NASDAQ
$3.19-0.04 (-1.39%)
$2.98
$7.18
$3.08
$3.21
EPS (TTM)$-1.44
P/E Ratio
Dividend Yield
Market Cap$1.57B
Volume10.74M
Prev Close$3.23
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$35.5M-$108.1M$-0.1759.8%-304.2%
Q3 '25$5.2M-$162.3M$-0.36-183.8%-3135.3%
Q2 '25$19.2M-$171.9M$-0.41-4.9%-894.2%
Q1 '25$14.7M-$202.5M$-0.50-48.0%-1373.3%
Q4 '24$4.5M-$178.9M$-0.57-181.4%-3935.5%
Q3 '24$26.1M-$95.8M$-0.3453.7%-367.5%
Q2 '24$14.4M-$97.5M$-0.4036.2%-676.6%
Q1 '24$13.8M-$91.4M$-0.3919.1%-662.4%
Get Your Daily Market Recap